Company Page

Rhizome AI

Founders

Rhizome AI is a generative AI-based regulatory intelligence platform that helps life science companies understand what the FDA thinks. The platform enables regulatory affairs teams to ask questions and receive answers backed by terabytes of regulatory and clinical databases from the US, EU, and other global health authorities. Unlike ChatGPT, Rhizome reads up to 1,000 documents per question, provides citations for each statement, and eliminates hallucinations. The company serves biotech and medtech companies, helping them navigate regulatory pathways and compliance requirements.

Company Founded in 2023